Melissa M. Chen, Lauren Parks Golding, Gregory N. Nicola
In 2020, the largest US health care payer, the Centers for Medicare & Medicaid Services (CMS) established payment for artificial intelligence (AI) through two different systems in the Medicare Physician Fee Schedule (MFPS) and the Inpatient Prospective Payment System (IPPS). Within the MPFS, a new CPT code was valued for an AI tool for diagnosis of diabetic retinopathy, IDx-RX. In the IPPS, Medicare established a New Technology Addon Payment (NTAP) for Viz.ai software, an AI algorithm that facilitates diagnosis and treatment of large-vessel occlusion strokes. This article describes reimbursement in these two payment systems and proposes future payment pathways for AI.
Read Full Article Here: https://doi.org/10.1148/ryai.2021210030